Uptake and Tolerance of Chemotherapy in Elderly Patients with Small Cell Lung Cancer and Impact on Survival
Table 5
Drug regimen received and number of cycles completed by treatment status.
Began chemotherapy (%)1
Dose reduction (%)2
Incomplete chemotherapy cycles (%)2
Total
117 (100)
40 (34)
56 (48)
Drug regimen
= 0.133
= 0.053
Carboplatin/etoposide
55 (47)
24 (44)
27 (49)
Cisplatin/etoposide
36 (31)
11 (31)
12 (33)
oposide
25 (21)
5 (20)
16 (64)
CAV
1 (1)
0 (0)
1 (100)
Numbers of cycles completed
1
30 (26)
6 (20)
2
12 (10)
4 (33)
3
14 (12)
5 (36)
4+4
61 (52)
25 (41)
Column percentage.
2Row percentage: denominator is the number who began chemotherapy in corresponding row.
3 values based on Fisher’s exact test.
4Defined as completed chemotherapy cycles.